Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.37	34.69	22.26	30.56	19.78	1.75
Short-Term Investments	66.03	71.82	44.55	57.04	64	-
Cash & Short-Term Investments	94.4	106.51	66.81	87.6	83.79	1.75
Cash Growth	89.24%	59.42%	-23.73%	4.55%	4675.54%	-13.44%
Accounts Receivable	0.08	0.1	0.09	0.1	0.1	-
Inventory	0.28	0.31	0.17	0.15	0.28	-
Other Current Assets	1.45	0.99	2.09	1.27	0.53	0.05
Total Current Assets	96.21	107.91	69.17	89.11	84.69	1.8
Net Property, Plant & Equipment	3.19	3.21	3.49	2.83	3.68	-
Long-Term Investments	-	2.5	2.5	2.5	2.5	160.02
Other Long-Term Assets	1.26	1.24	1.02	0.77	4.71	-
Total Assets	100.66	114.86	76.17	95.21	95.57	161.82
Accounts Payable	6.31	6.1	5.13	2.9	3.97	0
Accrued Expenses	6.59	9.89	6.08	5.15	5.38	0.16
Current Portion of Leases	0.79	0.75	0.55	0.65	0.7	-
Unearned Revenue	-	-	4.44	2.51	6.44	-
Other Current Liabilities	-	-	-	-	2.09	-
Total Current Liabilities	13.69	16.74	16.21	11.21	18.57	0.17
Long-Term Debt	32.12	30.75	14.29	-	9.49	-
Long-Term Leases	0.73	0.94	1.69	1.04	1.68	-
Other Long-Term Liabilities	3.15	3.06	11.03	14.92	13.3	5.6
Total Long-Term Liabilities	36	34.74	27.01	15.96	24.47	5.6
Total Liabilities	49.69	51.48	43.22	27.17	43.04	5.77
Preferred Stock	9.77	9.81	-	-	-	-
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	424.5	416.08	342.78	316.9	252.27	-
Accumulated Other Comprehensive Income	-0.04	0.06	0.05	-0.01	-0.01	-
Retained Earnings	-383.27	-362.58	-309.88	-248.85	-199.73	-3.94
Total Common Shareholders' Equity	50.97	63.38	32.96	68.04	52.53	-3.94
Minority Interest	-	-	-	-	-	160
Shareholders' Equity	50.97	63.38	32.96	68.04	52.53	156.06
Total Liabilities & Equity	100.66	114.86	76.17	95.21	95.57	161.82
Total Debt	33.64	32.44	16.53	1.69	11.87	0
Net Cash (Debt)	60.77	74.08	50.28	85.91	71.92	1.75
Net Cash Growth	-17.97%	47.32%	-41.47%	19.46%	3998.98%	-13.44%
Net Cash Per Share	1.13	1.55	1.37	2.59	4.80	0.20
Book Value	50.97	63.38	32.96	68.04	52.53	-3.94
Book Value Per Share	0.95	1.33	0.90	2.05	3.50	-0.45
Tangible Book Value	50.97	63.38	32.96	68.04	52.53	-3.94
Tangible Book Value Per Share	0.95	1.33	0.90	2.05	3.50	-0.45

SEC Filings: 10-K · 10-Q